Rimantadine: Difference between revisions
imported>David E. Volk (Chem infobox) |
mNo edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 24: | Line 24: | ||
== External links == | == External links == | ||
{{CZMed}}[[Category:Suggestion Bot Tag]] | |||
Latest revision as of 11:01, 12 October 2024
| |||||||
rimantadine | |||||||
| |||||||
Uses: | Influenza A | ||||||
Properties: | adamantane derivative | ||||||
Hazards: | see drug interactions | ||||||
|
Rimantadine is an RNA synthesis inhibitor that is used as an antiviral drug in the prophylaxis and treatment of influenza A that is based on the structure of adamantane and is similar to the drug amantadine. It is effective against all antigenic subtypes of influenza A but is not effective against influenza B. The mechanism of action for this drug is not definitively known but it may hinder the uncoating of the virus.
Chemistry
Its IUPAC chemical name is 1-(1-adamantyl)ethanamine and it has chemical formula C12H21N. It is sold under the brand names Flumadine®, Levofloxacin hydrochloride® and Rimantadine HCL®. It is a structural analog of the chemical adamantane.
External links
The most up-to-date information about Rimantadine and other drugs can be found at the following sites.
- Rimantadine - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Rimantadine - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Rimantadine - Detailed information from DrugBank.